The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Safety and Efficacy of Oxcarbazepine: Results of Randomized, Double‐Blind Trials
Open accessAbstract
Oxcarbazepine is approved as monotherapy and adjunctive therapy for partial seizures with and without secondarily generalized seizures in adults and as adjunctive therapy for partial‐onset seizures in children aged 4–16 years. The clinical development of oxcarbazepine is different from the newer antiepileptic drugs (AEDs) in the extent and concordance of results across clinical trials. The safety and efficacy of oxcarbazepine was evaluated in adjunctive therapy trials, in comparative monotherapy trials with classic AEDs in adults and children with newly diagnosed epilepsy, in monotherapy therapeutic failure design trials in patients with refractory partial seizures, and in trigeminal neuralgia and affective disorder. The results of oxcarbazepine in treating epilepsy are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mogens Dam (Chairman), R. E. (1989) · Epilepsy Research · doi:10.1016/0920-1211(89)90070-3 · Cited by 393
A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome
Sachdeo, R. C., Glauser, T. A., Ritter, F., Reife, R., Lim, P., Pledger, G., & the Topiramate YL Study Group (1999) · Neurology · doi:10.1212/wnl.52.9.1882 · Cited by 380
Guerreiro, M. M., Vigonius, U., Pohlmann, H., de Manreza, M. L. G., Fejerman, N., Antoniuk, S. A., & Moore, A. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00025-9 · Cited by 241
Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy
(2000) · Epilepsia · doi:10.1111/j.1499-1654.2000.001597.x · Cited by 225
Christe, W., Krämer, G., Vigonius, U., Pohlmann, H., Steinhoff, B. J., Brodie, M. J., & Moore, A. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(96)01013-3 · Cited by 216
Bill, P. A., Vigonius, U., Pohlmann, H., Guerreiro, C. A. M., Kochen, S., Saffer, D., & Moore, A. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00024-7 · Cited by 216
Adjunctive therapy with oxcarbazepine in children with partial seizures
Glauser, T. A., Nigro, M., Sachdeo, R., Pasteris, L. A., Weinstein, S., Abou-Khalil, B., Frank, L. M., Grinspan, A., Guarino, T., Bettis, D., et al. (2000) · Neurology · doi:10.1212/wnl.54.12.2237 · Cited by 173
Clinical Pharmacology and Pharmacokinetics of Oxcarbazepine
Lloyd, P. M., Flesch, G., & Dieterle, W. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb05938.x · Cited by 144
Comparison of oxcarbazepine and carbamazepine: a double-blind study
Reinikainen, K. J., Keränen, T., Halonen, T., Komulainen, H., & Riekkinen, P. J. (1987) · Epilepsy Research · doi:10.1016/0920-1211(87)90003-9 · Cited by 143
Possible Interaction Between Oxcarbazepine and an Oral Contraceptive
Jensen, P. K., Saano, V., Haring, P., Svenstrup, B., & Menge, G. P. (1992) · Epilepsia · doi:10.1111/j.1528-1157.1992.tb01773.x · Cited by 125
Liver Enzyme Induction and Serum Lipid Levels After Replacement of Carbamazepine with Oxcarbazepine
Isojärvi, J. I. T., Pakarinen, A., Rautio, A., Pelkonen, O., & Myllylä, V. V. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb01792.x · Cited by 98
Wamil, A. W., Schmutz, M., Portet, C., Feldmann, K. F., & McLean, M. J. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90787-0 · Cited by 72
Oxcarbazepine Does Not Affect the Anticoagulant Activity of Warfarin
Krämer, G., Tettenborn, B., Jensen, P. K., Menge, G. P., & Stoll, K.-D. (1992) · Epilepsia · doi:10.1111/j.1528-1157.1992.tb01772.x · Cited by 66
Absence of interaction between oxcarbazepine and erythromycin
Keränen, T., Jolkkonen, J., Pk, J., et al. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb05051.x · Cited by 62
The role of COX-2 in intestinal cancer
Williams, C. S., Shattuck-Brandt, R. L., & DuBois, R. N. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.1.1 · Cited by 60
Estimating neuron dendritic length in 3D from total vertical projections and from vertical slices
Howard, C. V., Cruz-Orive, L. M., & Yaegashi, H. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb05033.x · Cited by 46
Faigle, J. W., & Menge, G. P. (1990) · Behavioural Neurology · doi:10.1155/1990/917164 · Cited by 41
Cited by
EFNS guidelines on pharmacological treatment of neuropathic pain
Attal, N., Cruccu, G., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T., Sampaio, C., Sindrup, S., & Wiffen, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01511.x · Cited by 880
AAN-EFNS guidelines on trigeminal neuralgia management
Cruccu, G., Gronseth, G., Alksne, J., Argoff, C., Brainin, M., Burchiel, K., Nurmikko, T., & Zakrzewska, J. M. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02185.x · Cited by 726
Gronseth, G., Cruccu, G., Alksne, J., Argoff, C., Brainin, M., Burchiel, K., Nurmikko, T., & Zakrzewska, J. M. (2008) · Neurology · doi:10.1212/01.wnl.0000326598.83183.04 · Cited by 607
Cruccu, G., Di Stefano, G., & Truini, A. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1914484 · Cited by 464
Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments
Gambeta, E., Chichorro, J. G., & Zamponi, G. W. (2020) · Molecular Pain · doi:10.1177/1744806920901890 · Cited by 376
Metadata
- Authors
- Beydoun, A.
- Venue
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Publisher
- Wiley
- Published
- 2000-08
- Volume
- 20
- Issue
- 8P2
- Pages
- 152S-158S
- ISSN
- 0277-0008 (ISSN-L)
- 1875-9114
- OpenAlex
- W1992206505
- Cited by
- 252
- References
- 17
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.